HOLLY GONZALEZ: Open Payments
NPI 1952912768 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 13 payments from 8 companies in 2025. Trend: 2023 $333 · 2024 $351 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Lilly USA, LLC | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| PFIZER INC. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: FARXIGA, REXULTI, TRELEGY ELLIPTA, KISUNLA, MOUNJARO, Ozempic, OTEZLA, BREZTRI.
Industry payments across NJ — which companies pay providers there.
